Charles River Laboratories International (CRL) Cash from Investing Activities (2009 - 2026)

Charles River Laboratories International has reported Cash from Investing Activities for 18 years, with the latest figure at $28.1 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 175.25% year-over-year to $28.1 million in Q2 2026; TTM through Jun 2026 was -$506.3 million, a 180.87% decrease from a year earlier, with the FY2025 full-year figure at -$209.3 million, up 14.59% from the prior year.
• Cash from Investing Activities was $28.1 million for Q2 2026 at Charles River Laboratories International, up from -$407.8 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $44.4 million in Q4 2022, with the low at -$462.1 million in Q2 2022.
• Average Cash from Investing Activities over 5 years is -$111.4 million, with a median of -$78.1 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 376.88% in 2022, then slumped 796.78% in 2026.
• Over 5 years, Cash from Investing Activities stood at $44.4 million in 2022, then slumped by 637.08% to -$238.4 million in 2023, then jumped by 68.07% to -$76.1 million in 2024, then slipped by 21.95% to -$92.8 million in 2025, then jumped by 130.27% to $28.1 million in 2026.
• The last three Cash from Investing Activities figures came in at $28.1 million (Q2 2026), -$407.8 million (Q1 2026), and -$92.8 million (Q4 2025), per Business Quant data.